Riskpilot← Back to searchSign inGet full accessKringlantand AB
ABActiveOrg 5567719231Köpmangatan 3Dental practice care activities · NACE 8623Est. 20085-9 employees
Revenue 2024
SEK 7,1M
+13% vs 2023
EBITDA margin
39.1%
+36% vs 2023
Equity ratio
78.4%
Financial strength
Net profit 2024
SEK 1,8M
+54% vs 2023
| Revenue | SEK 7,1M | +13% |
| EBITDA | SEK 2,8M | +36% |
| Net profit | SEK 1,8M | +54% |
| Total assets | SEK 4,7M | +8% |
| Equity | SEK 3,6M | +39% |
| Employees | — | — |
Legal name
Kringlantand AB
Org number
5567719231
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
8 december 2008
Share capital
SEK 100 000
Employees
5-9
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget skall bedriva tandvård och därmed förenlig verksamhet.
Address
Köpmangatan 3
Email
info@kringlankliniken.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 581 | 6 692 | 6 539 | 6 288 | 7 078 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 2 718 | 2 428 | 2 352 | 2 038 | 2 771 |
| Depreciation & amort. | −189 | −617 | −534 | −534 | −534 |
| EBIT | 2 529 | 1 811 | 1 818 | 1 504 | 2 237 |
| Net financials | −12 | −61 | −60 | −45 | −12 |
| Profit before tax | 2 517 | 1 751 | 1 758 | 1 458 | 2 250 |
| Tax | −548 | −373 | −286 | −301 | −472 |
| Net profit | 1 969 | 1 378 | 1 472 | 1 157 | 1 778 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 144 | 4 158 | 4 260 | 4 302 | 4 657 |
| Equity | 2 105 | 1 584 | 2 264 | 2 621 | 3 649 |
| Long-term debt | 1 676 | 1 393 | 826 | 543 | 0 |
| Short-term debt | 1 362 | 1 181 | 1 170 | 1 138 | 1 007 |
| Total debt | 3 038 | 2 574 | 1 996 | 1 681 | 1 007 |
EBITDA margin
39.1%
This company
15.8%
Market median
+147% vs market
20202024
Equity ratio
78.4%
This company
38.2%
Market median
+105% vs market
20202024
Return on equity
48.7%
This company
18.4%
Market median
+165% vs market
20202024
Net profit margin
25.1%
This company
8.1%
Market median
+210% vs market
20202024
Asset turnover
1.52×
This company
1.12×
Market median
+36% vs market
20202024
Debt / equity
0.28×
This company
0.62×
Market median
+55% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MM | Audit | 2025 |
| Former (1) | ||
AB Audit | Audit | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2025 | |
| Deputy Board Member | 2025 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2025 | |
| Board of Directors | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Kringlantand AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Malin Maria Heléne Ståhl | Audit | 0 companies |
| Anna Bigitta Sundman | Audit | 0 companies |
| Kennedy Cankalp | Board of Directors | 0 companies |
| Diana d'Agostinis Jomsvik | Deputy Board Member | 0 companies |
| Josef Aslan | Deputy Board Member | 0 companies |
| Leif Jomsvik | Board of Directors | 0 companies |